Nephrogenic systemic fibrosis risk and liver disease

International Journal of Nephrology

Volumn 2014, Issue , 2014, Pages

  Hanna, Robert F ^a   Finkelstone, Lee A ^a   Chow, Daniel S ^a   Miloushev, Vesselin Z ^a   Escudero, Mark R ^a   Lagana, Stephen M ^a   Prince, Martin R ^a  

^a Department of Radiology Columbia University New York Presbyterian Hospital ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84899538366     PISSN: 2090214X     EISSN: 20902158     Source Type: Journal    
DOI: 10.1155/2014/679605     Document Type: Article

References (27)

1. Bruix J., Sherman M., Management of hepatocellular carcinoma. Hepatology 2005 42 5 1208 1236 2-s2.0-28844480321 10.1002/hep.20933
2. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., Montalto F., Ammatuna M., Morabito A., Gennari L., Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. The New England Journal of Medicine 1996 334 11 693 699 2-s2.0-0345299824 10.1056/NEJM199603143341104
3. Wong L. L., Current status of liver transplantation for hepatocellular cancer. The American Journal of Surgery 2002 183 3 309 316 2-s2.0-0036203758 10.1016/S0002-9610(02)00785-7
4. United Network for Organ Sharing, Organ distribution: allocation of livers. Policy 2010 3.6. http://optn.transplant.hrsa.gov/policiesAndBylaws/ policies.asp
5. Colli A., Fraquelli M., Casazza G., Massironi S., Colucci A., Conte D., Duca P., Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. The American Journal of Gastroenterology 2006 101 3 513 523 2-s2.0-33644763305 10.1111/j.1572-0241.2006.00467.x
6. Cowper S. E., Robin H. S., Steinberg S. M., Su L. D., Gupta S., LeBoit P. E., Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. The Lancet 2000 356 9234 1000 1001 2-s2.0-0034675322
7. Grobner T., Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrology Dialysis Transplantation 2006 21 4 1104 1108 2-s2.0-33645289942 10.1093/ndt/gfk062
8. Marckmann P., Skov L., Rossen K., Dupont A., Damholt M. B., Heaf J. G., Thomsen H. S., Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. Journal of the American Society of Nephrology 2006 17 9 2359 2362 2-s2.0-33748049106 10.1681/ASN.2006060601
9. Perez-Rodriguez J., Lai S., Ehst B. D., Fine D. M., Bluemke D. A., Nephrogenic systemic flbrosis: incidence, associations, and effect of risk factor assessment-report of 33 cases. Radiology 2009 250 2 371 377 2-s2.0-61749102915 10.1148/radiol.2502080498
10. Altun E., Martin D. R., Wertman R., Lugo-Somolinos A., Fuller E. R. III, Semelka R. C., Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy-report from two U.S. universities. Radiology 2009 253 3 689 696 2-s2.0-73949137773 10.1148/radiol.2533090649
11. EMEA, Assessment report for Gadolinium-containing contrast agents. Assessment Report 2010 EMEA/H/A-31/1097. http://www.lsw.uni-heidelberg.de/users/ christlieb/teaching/UKStaSS10/R-refman.pdf
12. Mazhar S. M., Shiehmorteza M., Kohl C. A., Middleton M. S., Sirlin C. B., Nephrogenic systemic fibrosis in liver disease: a systematic review. Journal of Magnetic Resonance Imaging 2009 30 6 1313 1322 2-s2.0-73649142429 10.1002/jmri.21983
13. R Development Core Team, R: A Language and Environment for Statistical Computing 2013 Vienna, Austria R Foundation for Statistical Computing
14. Gelman A., Carlin J. B., Stern H. S., Rubin D. B., Bayesian Data Analysis 1997 London, UK Chapman & Hall
15. Befeler A. S., Hayashi P. H., di Bisceglie A. M., Liver transplantation for hepatocellular carcinoma. Gastroenterology 2005 128 6 1752 1764 2-s2.0-18844447432 10.1053/j.gastro.2005.03.033
16. Bharat A., Brown D. B., Crippin J. S., Gould J. E., Lowell J. A., Shenoy S., Desai N. M., Chapman W. C., Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. Journal of the American College of Surgeons 2006 203 4 411 420 2-s2.0-33748791188 10.1016/j.jamcollsurg.2006.06.016
17. Hueper K., Elalfy M., Laenger F., Halter R., Rodt T., Galanski M., Borlak J., PET/CT imaging of c-Myc transgenic mice identifies the genotoxic N-Nitroso-Diethylamine as carcinogen in a Short-Term cancer bioassay. PLoS ONE 2012 7 2 2-s2.0-84856434585 10.1371/journal.pone.0030432 e30432
18. Kim S. E., Lee H. C., Shim J. H., Park H. J., Kim K. M., Kim P. N., Shin Y. M., Yu E. S., Chung Y.-H., Suh D. J., Noninvasive diagnostic criteria for hepatocellular carcinoma in hepatic masses >2 cm in a hepatitis B virus-endemic area. Liver International 2011 31 10 1468 1476 2-s2.0-80053982942 10.1111/j.1478-3231.2011.02529.x
19. Boyd A. S., Zic J. A., Abraham J. L., Gadolinium deposition in nephrogenic fibrosing dermopathy. Journal of the American Academy of Dermatology 2007 56 1 27 30 2-s2.0-33845702376 10.1016/j.jaad.2006.10.048
20. Maloo M., Abt P., Kashyap R., Younan D., Zand M., Orloff M., Jain A., Pentland A., Scott G., Bozorgzadeh A., Nephrogenic systemic fibrosis among liver transplant recipients: a single institution experience and topic update. American Journal of Transplantation 2006 6 9 2212 2217 2-s2.0-33746879941 10.1111/j.1600-6143.2006.01420.x
21. Chiu H., Wells G., Carag H., Canova E., Firpi R. J., Nephrogenic fibrosing dermopathy: a rare entity in patients awaiting liver transplantation. Liver Transplantation 2004 10 3 465 466 2-s2.0-1642366567 10.1002/lt.20068
22. Nephrogenic Systemic Fibrosis: Attorneys Experienced in Drug Product Liability and Medical Malpractice Cases, 2011, http://www.rcrsd.com/dangerous- medical-devices/gadolinium-nsf/
23. Sadowski E. A., Bennett L. K., Chan M. R., Wentland A. L., Garrett A. L., Garrett R. W., Djamali A., Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007 243 1 148 157 2-s2.0-34147193807 10.1148/radiol.2431062144
24. Sherman D. S., Fish D. N., Teitelbaum I., Assessing renal function in cirrhotic patients: problems and pitfalls. American Journal of Kidney Diseases 2003 41 2 269 278 2-s2.0-0037310730 10.1053/ajkd.2003.50035
25. Ng C. K., Chan M. H. M., Tai M. H. L., Lam C. W. K., Hepatorenal syndrome. The Clinical Biochemist Reviews 2007 28 1 11 17
26. Prince M. R., Zhang H., Morris M., MacGregor J. L., Grossman M. E., Silberzweig J., DeLapaz R. L., Lee H. J., Magro C. M., Valeri A. M., Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology 2008 248 3 807 816 2-s2.0-51549109381 10.1148/radiol.2483071863
27. Zou Z., Ma L., Nephrogenic systemic fibrosis: review of 408 biopsy-confirmed cases. Indian Journal of Dermatology 56 1 65 73